MetaCap

AngioDynamics (ANGO) vs Utah Medical Products (UTMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Utah Medical Products (UTMD) has outperformed AngioDynamics (ANGO) over the past year, gaining 16.5% versus a gain of 1.0%. Over five years, UTMD leads with a -17.9% price change compared with -59.0% for ANGO. AngioDynamics is the larger company by market cap ($472.3 million vs $234.5 million), about 2.0 times the size.

Utah Medical Products pays a dividend yielding 1.67%, while AngioDynamics does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANGO+0.99%UTMD+16.47%
+48%+15%-18%
Oct 8, 20251 yearOct 8, 2026
ANGO-56.71%UTMD-19.16%
+37%-24%-85%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANGO versus UTMD key metrics
MetricANGOUTMD
Share price$11.23$73.88
Market cap$472.27M$234.47M
1-day change-20.86%+0.58%
YTD return-12.54%+32.01%
1-year return+0.99%+16.47%
5-year return-58.97%-17.93%
P/E ratio (TTM)—22.52
EPS (TTM)$-0.88$3.28
Dividend yield0.00%1.67%
Annual dividend$0.00$1.24
52-week high$16.29$76.89
52-week low$9.39$53.66
Distance from 52-week high-31.06%-3.92%
Analyst consensusnone—
Avg. price target upside+78.09%—
Average volume557.83K34.56K
Shares outstanding42.05M3.17M
Employees632140
SectorHealthcareHealthcare
IndustryMedical Instruments & SuppliesMedical Instruments & Supplies

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • AngioDynamics is about 2.0 times larger than Utah Medical Products by market value ($472.27M vs $234.47M).
  • UTMD has outperformed ANGO by 15.5 percentage points over the past year.
  • Utah Medical Products offers a meaningfully higher dividend yield (1.67% vs 0.00%).

About AngioDynamics

ANGO stock →

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.

Healthcare · Medical Instruments & Supplies · 632 employees

About Utah Medical Products

UTMD stock →

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.

Healthcare · Medical Instruments & Supplies · 140 employees

ANGO vs UTMD FAQ

Which is bigger, AngioDynamics or Utah Medical Products?

AngioDynamics (ANGO) is larger, with a market capitalization of $472.27M compared with $234.47M for Utah Medical Products (UTMD).

Which stock has performed better over the past year, ANGO or UTMD?

UTMD returned +16.47% over the past 12 months, compared with +0.99% for ANGO (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, AngioDynamics or Utah Medical Products?

Utah Medical Products pays a dividend yielding 1.67%, while AngioDynamics does not currently pay a regular dividend.

Are AngioDynamics and Utah Medical Products in the same industry?

Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.

More comparisons